These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24965104)

  • 1. A web-based tool for improving adherence to sublingual immunotherapy.
    Tripodi S; Comberiati P; Di Rienzo Businco A
    Pediatr Allergy Immunol; 2014 Oct; 25(6):611-2. PubMed ID: 24965104
    [No Abstract]   [Full Text] [Related]  

  • 2. Sublingual immunotherapy in children.
    Tortajada-Girbés M; Rivas-Juesas C
    Allergol Immunopathol (Madr); 2018; 46(2):105-106. PubMed ID: 29458988
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on house dust mite immunotherapy: are more studies needed?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tonsillectomy on the efficacy of house dust mite sublingual immunotherapy.
    Refaat M; Ashour ZA; Farres MN; Eissa AM; Elsayed MM
    Allergol Immunopathol (Madr); 2015; 43(1):108-11. PubMed ID: 24388811
    [No Abstract]   [Full Text] [Related]  

  • 5. [YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].
    Masuyama K
    Arerugi; 2015 Sep; 64(9):1210-4. PubMed ID: 26657909
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of sublingual immunotherapy on Th2 type immunoreaction in patients with allergic rhinitis].
    Meng Q; Liang Y; Zhang W; Xie J; Su F; Yang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):90-3. PubMed ID: 24738309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy in children: the recent experiences.
    Pleskovic N; Bartholow A; Skoner DP
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):582-90. PubMed ID: 25188717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sublingual immunotherapy on serum IL-17 and IL-35 levels in children with allergic rhinitis or asthma].
    Ding LF; Chen Q; Li L; Liu JM; Zhang GP; Zhu XH; Wu AM; Ke JW; Dai YL; Wu CX
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1206-10. PubMed ID: 25523566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future challenges of subcutaneous and sublingual allergy immunotherapy for allergists in the United States.
    Nelson HS
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):278-280. PubMed ID: 29409924
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cutting-edge of medicine; Sublingual immunotherapy for allergic rhinitis].
    Konno W; Haruna S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):998-1005. PubMed ID: 26591351
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving long-term adherence to sublingual immunotherapy. Results of a proactive patient-centered management planning.
    Antico A
    Eur Ann Allergy Clin Immunol; 2022 Jan; 54(1):16-24. PubMed ID: 33728839
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonadherence to sublingual immunotherapy in allergic rhinitis: a real-life analysis.
    Wang T; Li Y; Wang F; Zhou C
    Int Forum Allergy Rhinol; 2017 Apr; 7(4):389-392. PubMed ID: 28151587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy.
    Katotomichelakis M; Riga M; Tripsianis G; Balatsouras D; Kourousis C; Danielides G; Giotakis E; Danielides V
    Ann Otol Rhinol Laryngol; 2015 Jun; 124(6):430-6. PubMed ID: 25539660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SUBLINGUAL IMMUNOTHERAPY].
    Gotoh M
    Arerugi; 2015 Aug; 64(8):1136-40. PubMed ID: 26522415
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual immunotherapy in children and its potential beneficial collateral effect on respiratory tract infections.
    Occasi F; De Castro G; Zicari AM; Indinnimeo L; Tancredi G; Duse M
    Curr Med Res Opin; 2015 May; 31(5):939-41. PubMed ID: 25753228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of phenotypes in the management of asthma].
    Laura E
    Soins; 2015 May; (795):11. PubMed ID: 26126371
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens: clinical evidence of cross-tolerance.
    Theodoropoulos DS; Morris MS; Morris DL
    Eur Rev Med Pharmacol Sci; 2015; 19(3):392-5. PubMed ID: 25720708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism and onset time of single dermatophagoides farina sublingual immunotherapy in patients with allergic rhinitis sensitized to dermatophagoides farina and dermatophagoides pteronyssinus].
    Tan H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):296-9. PubMed ID: 25185280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cytokine responses to house dust mite sublingual immunotherapy.
    Potter PC; Baker S; Fenemore B; Nurse B
    Ann Allergy Asthma Immunol; 2015 Apr; 114(4):327-34. PubMed ID: 25661658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.